What does Cerevel Therapeutics Holdings, Inc. do?

Jun 22 2025 07:06 PM IST
share
Share Via
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for neuroscience diseases. As of March 2024, it has a market cap of approximately $8.19 billion and reported a net profit loss of $132 million.
Overview:
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company in the Pharmaceuticals: Major industry, focusing on discovering and developing new therapies for neuroscience diseases.

Financial Snapshot:
Net Profit: -132 Million (Quarterly Results - Mar 2024)
Market cap: USD 8,191.47 Million (Mid Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 86.52%
Debt Equity: -0.89
Return on Equity: -80.13%
Price to Book: 14.51

Contact Details:
Address: 131 Dartmouth Street, Suite 502, BOSTON MA: 02116
Tel: 1 212 2842300
Fax: 1 302 6365454
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Cerevel Therapeutics Holdings, Inc.?
Jun 22 2025 06:18 PM IST
share
Share Via